Xoma | XOMA - Equity Capital And Reserves

Stock Price
41.75
Daily Change
-0.25 -0.60%
Monthly
5.40%
Yearly
54.69%
Q2 Forecast
41.02

Xoma reported $87.94M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -6.66B 3.39B Mar/2026
Agenus USD -221.22M 49.89M Mar/2026
Agios Pharmaceuticals USD 1.11B 84M Mar/2026
Ardelyx USD 148.62M 18.33M Mar/2026
aTyr Pharma USD 57.93M 82.05M Mar/2026
BioMarin Pharmaceutical USD 6.21B 125.11M Mar/2026
Celldex Therapeutics USD 456.23M 70.94M Mar/2026
Curis USD 5.46M 19.45M Dec/2025
Eli Lilly USD 31.2B 4.66B Mar/2026
Emergent BioSolutions USD 649.3M 47.9M Dec/2023
Incyte USD 5.62B 455.37M Mar/2026
MacroGenics USD 21.2M 34.39M Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
Novartis USD 46.13B 1.8B Dec/2025
Pfizer USD 90.1B 3.63B Mar/2026
Prothena USD 312.62M 32.14M Mar/2026
Regeneron Pharmaceuticals USD 31.42B 166.7M Mar/2026
Xoma USD 87.94M 15.5M Sep/2025